During transfusion management, which details should be documented for each transfusion event?

• A. Only the patient name.
• B. Unit numbers but not product type.
• C. Blood product type, amount transfused, transfusion start and end times, adverse reactions; crossmatch status and MTP activation status.
• D. No documentation required.

Answer: (C)

Accurate and complete documentation of every transfusion event supports patient safety, traceability, and proper clinical management. Recording the exact blood product type identifies exactly what was given (for example, red cells, plasma, platelets) so future care and reaction assessment are appropriate. Noting the amount transfused provides a record of the volume, helps avoid under- or overtransfusion, and supports inventory and dosing decisions. The start and end times create a precise timeline that lets clinicians correlate any symptoms or reactions with the transfusion and evaluate how quickly a response occurred. Documenting any adverse reactions, including what happened, when it started, how it was managed, and the outcome, is essential for patient safety, reporting, and quality improvement.

Including crossmatch status links the transfused units to the pretransfusion compatibility testing, which is crucial if a reaction or incompatibility issue arises. Indicating whether the massive transfusion protocol was activated signals a high-volume, emergent process that affects monitoring, resources, and documentation requirements. Together, these elements ensure a complete, auditable record that supports safe care and facilitates future investigations. Relying on only the patient name, or omitting these details, would leave critical information unavailable and could lead to safety gaps and delays in treatment.